A Study of HS248 in Patients With Advanced Solid Tumors

Clinical trial NCT05759234 · UNKNOWN

Trial details

NCT number: NCT05759234
Sponsor: Hanhui Pharmaceutical Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2022-11-15
Primary completion: 2023-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.